Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | LTK | P29376 | 1/20 | 0.31 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.31 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.31 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18965753 | 0.83 | TDP1 (0.38) | TDP1 | |
| SCHEMBL17865293 | 0.78 | NTRK1 (0.37) | ADORA2AADORA1NTRK1LTKTYRO3 | |
| SCHEMBL18909176 | 0.77 | NTRK1 (0.36) | ADORA2AADORA1NTRK1LTKTYRO3 | |
| SCHEMBL19303455 | 0.77 | — | — | |
| SCHEMBL17339845 | 0.77 | ALDH1A1 (0.36) | TDP1 | |
| SCHEMBL21610583 | 0.77 | ADORA3 (0.32) | ADORA2AADORA1ADORA2B | |
| SCHEMBL17865307 | 0.74 | — | — | |
| SCHEMBL15424496 | 0.73 | NTRK1 (0.35) | TDP1ADORA2AADORA1NTRK1LTK | |
| SCHEMBL19214697 | 0.72 | ALDH1A1 (0.34) | TDP1 | |
| SCHEMBL21515189 | 0.72 | SMN1; SMN2 (0.34) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11667650-B2 | Thieno-indeno-monomers and polymers | CLAP CO., LTD. (KR) | 2023-06-06 | — | — | US | disclosed |
| US-20220041617-A1 | THIENO-INDENO-MONOMERS AND POLYMERS | BASF SE (DE) | 2022-02-10 | — | — | US | disclosed |
| US-11225489-B2 | Thieno-indeno-monomers and polymers | BASF SE (DE) | 2022-01-18 | — | — | US | disclosed |
| US-20210384434-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | CLAP CO., LTD. (KR) | 2021-12-09 | — | — | US | disclosed |
| US-10793668-B2 | Naphthoindacenodithiophenes and polymers | CLAP CO., LTD. (KR) | 2020-10-06 | — | — | US | disclosed |
| WO-2020078815-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2020-04-23 | — | — | WO | disclosed |
| US-10388881-B2 | Sorting of carbon nanotubes | BASF SE (DE) | 2019-08-20 | — | — | US | disclosed |
| WO-2018104367-A2 | THIENO-INDENO-MONOMERS AND POLYMERS | BASF SE (DE) | 2018-06-14 | — | — | WO | disclosed |
| US-20170365791-A1 | HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTRONICS | BASF SE (DE) | 2017-12-21 | — | — | US | disclosed |
| US-20170229657-A1 | SORTING OF CARBON NANOTUBES | CLAP CO., LTD. (KR) | 2017-08-10 | — | — | US | disclosed |
| WO-2017097924-A1 | NAPHTHOINDACENODITHIOPHENES AND POLYMERS | BASF SE (DE) | 2017-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667650-B2 | Thieno-indeno-monomers and polymers | RPS21, OXER1, OXSR1 | TDP1 2729/4885ADORA2A 1761/4885ADORA1 838/4885 |
| US-20210384434-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | IPO11, CYP1B1, IDO1 | TDP1 1644/4885ADORA2A 3715/4885ADORA1 2640/4885 |
| US-20170365791-A1 | HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTRONICS | OR10J3, NR0B1, NR0B2 | TDP1 4545/4885ADORA2A 379/4885ADORA1 246/4885 |
| US-10793668-B2 | Naphthoindacenodithiophenes and polymers | RPS21, NR2C2, NR0B2 | TDP1 2741/4885ADORA2A 3494/4885ADORA1 2191/4885 |
| US-20220041617-A1 | THIENO-INDENO-MONOMERS AND POLYMERS | RPS21, OXER1, OXSR1 | TDP1 2729/4885ADORA2A 1761/4885ADORA1 838/4885 |
| US-11225489-B2 | Thieno-indeno-monomers and polymers | TERT, TERB1, TERF2 | TDP1 1006/4885ADORA2A 1788/4885ADORA1 2052/4885 |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | IPO11, CYP1B1, IDO1 | TDP1 1644/4885ADORA2A 3715/4885ADORA1 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.